Physician profile
Patrick H Kee
NPI 1881600815
$14,145.53
in general payments reported to CMS, 2019-2025
23 companies · $4,198 in 2025
The $4,198 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.32 · 2020: $190 · 2022: $125 · 2023: $755 · 2024: $8,807 · 2025: $4,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $3,019 · Travel and Lodging: $4.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,735.00 |
| Food and Beverage | $3,019.13 |
| Travel and Lodging | $4.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11,843.05 | 2019-2025 | Repatha, Repatha |
| Cvrx, INC. | $355.61 | 2024-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $268.22 | 2024-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $221.81 | 2025 | Assure Wcd |
| Heartflow, INC. | $204.73 | 2025 | |
| W. L. Gore & Associates, INC. | $191.69 | 2024 | Gore Cardioform Septal Occluder |
| Lantheus Medical Imaging, INC. | $166.80 | 2023-2024 | Definity |
| Regeneron Healthcare Solutions, INC. | $160.33 | 2024 | Evkeeza, Praluent |
| Novo Nordisk INC | $105.10 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Canon Medical Systems USA, INC. | $98.83 | 2023 | Pet-Ct Scanner |
| Abbott Laboratories | $91.99 | 2024 | Merlin@Home |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.60 | 2023 | Lifevest |
| Medtronic, INC. | $71.40 | 2023-2024 | Venaseal |
| Kiniksa Pharmaceuticals International, Plc | $48.71 | 2024 | |
| Boston Scientific Corporation | $44.06 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $42.72 | 2023-2024 | Te7 Max, Te X |
| Novartis Pharmaceuticals Corporation | $33.73 | 2023 | |
| Edwards Lifesciences Corporation | $32.15 | 2025 | Sapien 3 Ultra Resilia |
| Regeneron Pharmaceuticals, INC. | $27.06 | 2025 | Evkeeza |
| Angiodynamics, INC. | $15.56 | 2023 | Alphavac |
| Ge Healthcare | $15.09 | 2025 | |
| Esperion Therapeutics, INC. | $13.66 | 2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.